Your personal download of today’s program invitations, prescribing information and more.
Janssen Pharmaceuticals, Inc. Advances in the Management of CAD/PAD: A New Treatment for Thrombotic Risk Reduction Saturday, Mar. 16, 2019 |
Sanofi Booth #1418 PRALUENT Injection: The Time to Treat is Now Saturday, Mar. 16, 2019 |
Novartis/Entresto Improving Outcomes for Hospitalized Patients with HFrEF: Looking Beyond Stabilization Saturday, Mar. 16, 2019 |
Best Vascular Novoste |
Pfizer Rare Disease Expert Insights Into a Deadly Disease: Transthyretin Amyloid Cardiomyopathy Saturday, Mar. 16, 2019 |
Pharma Nord Inc |
ACC.19: Complete Your Educational Experience |
ACC.19: Clinical Focus Sessions |